Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antineoplastic cryptophycin compounds

April 15, 1997

Immunogene therapy for cancer enters clinical trials

April 14, 1997

Novartis describes small-molecule signal transduction inhibitors

April 14, 1997

RPR cleared to market Taxotere in Malaysia and Hungary

April 11, 1997

Eisai prepares potent antitumor agents

April 11, 1997

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

UCSF receives NIH funding for research into anticancer protease inhibitors

April 11, 1997

Farnesyltransferase inhibitors from Zeneca

April 10, 1997

Pharma Mar describes antitumor compounds from marine sponge

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...